Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 12.45% |
| 4 | Miscellaneous | 11.59% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABCM
3176
DELISTED
Abcam PLC
ABCM
| $162K | ﹤0.01% |
10,788
-77,175
| -88% | -$1.16M |
|
3177
On Holding
ONON
$10B
| $161K | ﹤0.01% |
10,041
+3,498
| +53% | +$69.7K |
|
|
SOVO
3178
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $161K | ﹤0.01% |
11,295
-13,492
| -54% | -$197K |
|
|
OHPA
3179
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
| $161K | ﹤0.01% |
16,300
+15,300
| +1,530% | +$150K |
|
3180
Astronics
ATRO
$2.98B
| $160K | ﹤0.01% |
24,454
-236
| -1% | -$1.97K |
|
3181
CEVA Inc
CEVA
$1.02B
| $160K | ﹤0.01% |
6,123
-1,536
| -20% | -$49.3K |
|
3182
Eagle Bancorp Montana
EBMT
$171M
| $160K | ﹤0.01% |
8,402
-872
| -9% | -$16.9K |
|
3183
LSI Industries
LYTS
$786M
| $160K | ﹤0.01% |
20,839
+4,838
| +30% | +$33.7K |
|
|
TRST
3184
Trustco Bank Corp NY
TRST
$957M
| $159K | ﹤0.01% |
5,084
-873
| -15% | -$29K |
|
|
GHIXW
3185
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
| $159K | ﹤0.01% |
458,333
| – | – |
|
3186
The Honest Company
HNST
$568M
| $158K | ﹤0.01% |
45,195
+2,362
| +6% | +$8.67K |
|
3187
iShares S&P India Nifty 50 Index Fund
INDY
$511M
| $158K | ﹤0.01% |
3,750
| – | – |
|
3188
Myers Industries
MYE
$1.18B
| $158K | ﹤0.01% |
9,610
-1,705
| -15% | -$35.1K |
|
3189
Phreesia
PHR
$630M
| $158K | ﹤0.01% |
6,184
+613
| +11% | +$15.3K |
|
3190
Sotera Health
SHC
$5.23B
| $158K | ﹤0.01% |
23,171
+7,773
| +50% | +$129K |
|
|
CLVS
3191
DELISTED
Clovis Oncology, Inc.
CLVS
| $158K | ﹤0.01% |
132,775
+94,367
| +246% | +$147K |
|
3192
Global Water Resources
GWRS
$233M
| $157K | ﹤0.01% |
13,375
-71
| -0.5% | -$967 |
|
|
PLYM
3193
DELISTED
Plymouth Industrial REIT
PLYM
| $157K | ﹤0.01% |
9,302
-2,319
| -20% | -$44.9K |
|
3194
Modine Manufacturing
MOD
$10.5B
| $156K | ﹤0.01% |
12,101
-3,225
| -21% | -$45.3K |
|
|
FOCS
3195
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $155K | ﹤0.01% |
4,919
+2,008
| +69% | +$76.6K |
|
3196
NI Holdings
NODK
$302M
| $154K | ﹤0.01% |
11,479
-65
| -0.6% | -$937 |
|
3197
Noble Corp
NE
$6.84B
| $153K | ﹤0.01% |
5,175
-97
| -2% | -$2.87K |
|
3198
Latham Group
SWIM
$735M
| $153K | ﹤0.01% |
42,393
+40,187
| +1,822% | +$229K |
|
3199
Applied Optoelectronics
AAOI
$8.61B
| $152K | ﹤0.01% |
55,905
-315
| -0.6% | -$710 |
|
3200
Acco Brands
ACCO
$398M
| $152K | ﹤0.01% |
31,047
+183
| +0.6% | +$1.16K |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays deployed $5.45B of net new capital in Q3 2022, opening 261 new positions and adding to 1,854 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $873M trimmed.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.